Decipher Test for Prostate Cancer - Indications, Procedure & Results
Decipher test a genomic test for prostate cancer that determines the aggressiveness of the cancer and helps in planning the treatment course for the cancer.
Decipher test a genomic test for prostate cancer that determines the aggressiveness of the cancer and helps in planning the treatment course for the cancer.
‘Utilizing SBRT is safe as treatment for patients with 2 metastases in close proximity or 3-4 metastases regardless of proximity, in the following anatomic locations: peripheral lung, central lung, abdomen/pelvic, bone/osseous, spinal/paraspinal, cervical and liver.’
Tweet it Now
NRG-BR001 was initially designed and deployed by NRG Oncology's breast cancer team, then the team invited patients with lung cancer and prostate cancer to participate. The study accrued 36 patients between August 2014 and December 2017, 12 of which had breast cancer, 11 had non-small cell lung cancer, and 13 had prostate cancer. All patients in this study were followed for dose-limiting toxicity defined by any grade 3 through 5 adverse events that occurred either definitely or probably from SBRT within 6 months of receiving the treatment. These patients were categorized into seven different anatomic locations: bone/osseous (BO), spinal/paraspinal (SP), peripheral lung (PL), central lung (CL), abdominal/pelvic (AP), mediastinal/cervical (MC), and liver (L).
"While the SBRT dose schedule used in this trial is typical when treating single metastases, the patients that participated in NRG-BR001 had a median of three metastases, and displayed zero protocol-defined dose-limiting toxicities across the evaluable anatomic locations. We attribute this safety to the rigorous quality assurance and advanced imaging used by all participating centers which had to be credentialed before they were allowed to treat any patients that volunteered to participate on this trial," stated Steven J. Chmura, MD, PhD, Associate Professor of Radiation and Cellular Oncology at the University of Chicago Medicine and the lead author of the abstract.
Quiz on Prostate Cancer
Prostate cancer is fast gaining as a common cancer form among men; more threatening since its symptoms often go unnoticed until it’s too late. This quiz tests your knowledge on prostate cancer, its diagnosis and treatment options and is as mandatory for men as the screening tests mentioned here are!
Prostate cancer is fast gaining as a common cancer form among men; more threatening since its symptoms often go unnoticed until it’s too late. This quiz tests your knowledge on prostate cancer, its diagnosis and treatment options and is as mandatory for men as the screening tests mentioned here are!
Source-Eurekalert
Immunotherapy Shows Promising Result in Skin Cancer Patients with Brain Metastases
Patients with melanoma brain metastases (skin cancer spread to the brain) have a significant improvement from immunotherapies doubling their survival rates, study says.
Patients with melanoma brain metastases (skin cancer spread to the brain) have a significant improvement from immunotherapies doubling their survival rates, study says.
What�s New in Breast Cancer Brain Metastases Treatment
By using immune system, researchers are finding ways to improve treatment for patients with breast cancer brain metastases.
By using immune system, researchers are finding ways to improve treatment for patients with breast cancer brain metastases.
